{
    "Trade/Device Name(s)": [
        "illumigene\u00ae HSV 1&2 DNA Amplification Assay",
        "illumigene\u00ae HSV 1&2 External Control Kit"
    ],
    "Submitter Information": "Meridian Bioscience, Inc.",
    "510(k) Number": "K151046",
    "Predicate Device Reference 510(k) Number(s)": [
        "K133448"
    ],
    "Regulatory Class": "Class II",
    "Product Code(s)": [
        "PGI"
    ],
    "Summary Letter Date": "July 17, 2015",
    "Summary Letter Received Date": "April 20, 2015",
    "Submission Date": "April 16, 2015",
    "Regulation Number(s)": [
        "21 CFR 866.3309"
    ],
    "Regulation Name(s)": [
        "Herpes virus nucleic acid-based cutaneous and mucocutaneous lesion panel"
    ],
    "Analyte Class(es)": [
        "virology",
        "genetic molecular"
    ],
    "Analyte(s)": [
        "Herpes simplex virus type 1 DNA",
        "Herpes simplex virus type 2 DNA"
    ],
    "Specimen Type(s)": [
        "Cutaneous lesion swab",
        "Mucocutaneous lesion swab"
    ],
    "Specimen Container(s)": [
        "Swab in viral transport medium"
    ],
    "Instrument(s)/Platform(s)": [
        "illumipro-10\u2122 Automated Isothermal Amplification and Detection System"
    ],
    "Method(s)/Technology(ies)": [
        "Loop-mediated isothermal DNA amplification (LAMP)"
    ],
    "Methodologies": [
        "DNA amplification",
        "Qualitative detection"
    ],
    "Submission Type(s)": [
        "Assay",
        "Control Kit",
        "System"
    ],
    "Document Summary": "FDA 510(k) summary for illumigene HSV 1&2 DNA Amplification Assay for qualitative detection and differentiation of HSV-1 and HSV-2 using LAMP technology.",
    "Indications for Use Summary": "Qualitative in vitro diagnostic test for direct detection and differentiation of HSV-1 and HSV-2 DNA in cutaneous and mucocutaneous lesion specimens from symptomatic patients, as an aid in diagnosis of HSV infection, for laboratory use only.",
    "fda_folder": "Microbiology"
}